Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Guggenheim analyst Subbu Nambi initiated coverage on Twist Bioscience Corporation TWST with a Buy rating, while announcing a price target of $53. Twist Bioscience shares gained 6.8% to close at $46.98 on Tuesday. See how other analysts view this stock.
- BMO Capital analyst Fadi Chamoun initiated coverage on Old Dominion Freight Line, Inc. ODFL with an Outperform rating and announced a price target of $210. Old Dominion Freight Line shares rose 1.7% to settle at $172.14 on Tuesday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Troy Jensen initiated coverage on Proto Labs, Inc. PRLB with an Overweight rating, while announcing a price target of $44. Proto Labs shares fell 0.2% to settle at $30.32 on Tuesday. See how other analysts view this stock.
- Goldman Sachs analyst Madhu Kumar initiated coverage on Jazz Pharmaceuticals plc JAZZ with a Buy rating and announced a price target of $169. Jazz Pharmaceuticals shares fell 1.2% to close at $104.48 on Tuesday. See how other analysts view this stock.
- Craig-Hallum analyst Jeff Van Rhee initiated coverage on Spire Global, Inc. SPIR with a Buy rating, while announcing a price target of $13. Spire Global shares rose 1.1% to settle at $9.33 on Tuesday. See how other analysts view this stock.
Check This Out: Top 4 Health Care Stocks That Are Preparing To Pump This Month
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in